A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation




TekijätKytö Ville, Saraste Antti, Rautava Päivi, Tornio Aleksi

KustantajaWILEY

Julkaisuvuosi2022

JournalBasic and Clinical Pharmacology and Toxicology

Tietokannassa oleva lehden nimiBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Lehden akronyymiBASIC CLIN PHARMACOL

Vuosikerta130

Numero6

Aloitussivu655

Lopetussivu665

Sivujen määrä11

ISSN1742-7835

DOIhttps://doi.org/10.1111/bcpt.13733

Verkko-osoitehttps://doi.org/10.1111/bcpt.13733

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/175200673


Tiivistelmä
Digoxin is used for rate control in atrial fibrillation (AF), but evidence for its efficacy and safety after myocardial infarction (MI) is scarce and mixed. We studied post-MI digoxin use effects on AF patient outcomes in a nationwide registry follow-up study in Finland. Digoxin was used by 18.6% of AF patients after MI, with a decreasing usage trend during 2004-2014. Baseline differences in digoxin users (n = 881) and controls (n = 3898) were balanced with inverse probability of treatment weight adjustment. The median follow-up was 7.4 years. Patients using digoxin after MI had a higher cumulative all-cause mortality (77.4% vs. 72.3%; hazard ratio [HR]: 1.19; confidence interval [CI]: 1.07-1.32; p = 0.001) during a 10-year follow-up. Mortality differences were detected in a subgroup analysis of patients without baseline heart failure (HF) (HR: 1.23; p = 0.019) but not in patients with baseline HF (HR: 1.05; p = 0.413). Cumulative incidences of HF hospitalizations, stroke and new MI were similar between digoxin group and controls. In conclusion, digoxin use after MI is associated with increased mortality but not with HF hospitalizations, new MI or stroke in AF patients. Increased mortality was detected in patients without baseline HF. Results suggest caution with digoxin after MI in AF patients, especially in the absence of HF.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 14:39